Top

Published in:

01-12-2016

Biography—Li Ma

Published in: Cancer and Metastasis Reviews | Issue 4/2016

Excerpt

Dr. Li Ma is an Associate Professor in the Department of Experimental Radiation Oncology at The University of Texas MD Anderson Cancer Center. Dr. Ma received her bachelor’s degree in biology from Peking University in 2001. After completing her Ph.D. study at Sloan-Kettering Institute and Cornell University Weill Graduate School of Medical Sciences in 2006, she became a postdoctoral fellow at the Whitehead Institute for Biomedical Research. She joined the faculty of MD Anderson as an Assistant Professor in 2010 and was promoted to Associate Professor with tenure in 2015. …

Title: Biography—Li Ma
Publication date: 01-12-2016
Publisher: Springer US
Published in: Cancer and Metastasis Reviews / Issue 4/2016
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-016-9641-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2016

Cell lineage determinants as regulators of breast cancer metastasis

Preface

Immunotherapy for breast cancer: past, present, and future

EMT, cell plasticity and metastasis

Current challenges of metastatic breast cancer

The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer